9(S),12(S),13(S)-TriHODE
(Synonyms: Corchorifatty Acid F,FA 18:2;O3,Fulgidic Acid,9(S),12(S),13(S)-trihydroxy-10(E),15(Z)-ODE,9(S),12(S),13(S)-Trihydroxyoctadecadienoic Acid,9(S),12(S),13(S)-trihydroxy-trans-10,cis-15-Octadecadienoic Acid) 目录号 : GC916929(S),12(S),13(S)-TriHODE is an α-linolenic acid-derived oxylipin that has been found in C. olitorius.
Cas No.:95341-44-9
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
9(S),12(S),13(S)-TriHODE is an α-linolenic acid-derived oxylipin that has been found in C. olitorius.1,2,3 It is formed from α-linolenic acid via a 9(S)-HpOTrE intermediate.[1] Tumor levels of 9(S),12(S),13(S)-TriHODE are decreased compared with adjacent healthy tissue in dogs with mammary cancer.[4]
References:
[1].Hamberg, M., Sanz, A., Rodriguez, M.J., et al.Activation of the fatty acid α-dioxygenase pathway during bacterial infection of tobacco leaves. Formation of oxylipins protecting against cell deathJ. Biol. Chem.278(51)51796-51805(2003).
[2].Yoshikawa, M., Murakami, T., Shimada, H., et al.Medicinal foodstuffs. XIV. On the bioactive constituents of moroheiya. (2): New fatty acids, corchorifatty acids A, B, C, D, E, and F, from the leaves of Corchorus olitorius L. (Tiliaceae): Structures and inhibitory effect on NO production in mouse peritoneal macrophagesChem. Pharm. Bull. (Tokyo)46(6)1008-1014(1998).
[3].Prost, I., Dhondt, S., Rothe, G., et al.Evaluation of the antimicrobial activities of plant oxylipins supports their involvement in defense against pathogensPlant Physiol.139(4)1902-1913(2005).
[4].Yu, C., Zheng, H.-H., Zhang, Y.-Z., et al.Identification of canine mammary tumor-associated metabolites using untargeted metabolomicsTheriogenology21184-96(2023).
Cas No. | 95341-44-9 | SDF | Download SDF |
别名 | Corchorifatty Acid F,FA 18:2;O3,Fulgidic Acid,9(S),12(S),13(S)-trihydroxy-10(E),15(Z)-ODE,9(S),12(S),13(S)-Trihydroxyoctadecadienoic Acid,9(S),12(S),13(S)-trihydroxy-trans-10,cis-15-Octadecadienoic Acid | ||
分子式 | C18H32O5 | 分子量 | 328.4 |
溶解度 | N/A | 储存条件 | -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 3.0451 mL | 15.2253 mL | 30.4507 mL |
5 mM | 0.609 mL | 3.0451 mL | 6.0901 mL |
10 mM | 0.3045 mL | 1.5225 mL | 3.0451 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。